Literature DB >> 19595579

Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: an [11C]diprenorphine PET study.

Tim M Williams1, Simon J C Davies, Lindsay G Taylor, Mark R C Daglish, Alexander Hammers, David J Brooks, David J Nutt, Anne Lingford-Hughes.   

Abstract

The importance of the opioid receptor system in substance dependence is increasingly recognised. We used PET with the non-selective tracer [11C]diprenorphine to examine opioid receptor binding in early abstinence from alcohol dependence and the relationship to craving. We recruited 11 alcohol dependent patients and 13 controls. Subjects underwent one [11C]diprenorphine PET scan in early abstinence from dependent alcohol use (approximately 2 weeks) and 2 months later if continuously abstinent. Global and regional [11C]diprenorphine volumes of distribution (VD) were increased in alcohol dependent patients compared with controls but did not reach significance. We demonstrated a correlation between global and regional [11C]diprenorphine VD and craving in alcohol dependent patients which persisted in the anterior cingulate cortex into extended abstinence. This confirms previous work showing increased opioid receptor availability in early abstinence from substances of abuse and correlation with craving suggesting that the opioid system plays a fundamental role in this phase of addiction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19595579     DOI: 10.1016/j.euroneuro.2009.06.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  27 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  Targeted opioid receptor antagonists in the treatment of alcohol use disorders.

Authors:  Mark J Niciu; Albert J Arias
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

Review 3.  Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

Review 4.  [Nalmefene: a novel pharmacotherapeutic option for alcoholism].

Authors:  M Soyka
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

5.  Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.

Authors:  Elise M Weerts; Gary S Wand; Hiroto Kuwabara; Cynthia A Munro; Robert F Dannals; John Hilton; J James Frost; Mary E McCaul
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

Review 6.  The opioid receptors as targets for drug abuse medication.

Authors:  Florence Noble; Magalie Lenoir; Nicolas Marie
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

Review 7.  Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder.

Authors:  N W Gilpin; J L Weiner
Journal:  Genes Brain Behav       Date:  2016-11-18       Impact factor: 3.449

8.  Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain.

Authors:  M O Martel; A D Wasan; R N Jamison; R R Edwards
Journal:  Drug Alcohol Depend       Date:  2013-04-22       Impact factor: 4.492

9.  Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.

Authors:  Huiping Zhang; Joel Gelernter; Jeffrey R Gruen; Henry R Kranzler; Aryeh I Herman; Arthur A Simen
Journal:  J Hum Genet       Date:  2010-03-19       Impact factor: 3.172

Review 10.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.